Finance

Lists
1795:TPE
Lotus Pharmaceutical Co Ltd
NT$126.00
-1.56%
(-2.00) 1D
Nov 17, 1:30:12 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1795...
Open
NT$127.50
High
NT$128.00
Low
NT$121.00
Mkt. cap
34.02B
Avg. vol.
1.48M
Volume
2.40M
Dividend
2.01%
Quarterly dividend
NT$0.63
Ex-dividend date
Aug 31, 2026
P/E ratio
8.90
52-wk high
NT$364.76
52-wk low
NT$121.00
EPS
NT$14.16
No. of employees
1K
Open
NT$127.50
High
NT$128.00
Low
NT$121.00
Mkt. cap
34.02B
Avg. vol.
1.48M
Volume
2.40M
Dividend
2.01%
Quarterly dividend
NT$0.63
Ex-dividend date
Aug 31, 2026
P/E ratio
8.90
52-wk high
NT$364.76
52-wk low
NT$121.00
EPS
NT$14.16
No. of employees
1K
News stories
From web sources and news partners
About Lotus Pharmaceutical Co Ltd
CEOPetar Vazharov
Employees1.1K
Founded1966
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
6.26B
8.64B
8.81B
7.37B
Cost of goods sold
2.80B
4.26B
4.08B
3.87B
Cost of revenue
2.80B
4.26B
4.08B
3.87B
Research and development expenses
-33.26M
279.59M
246.02M
353.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.70B
2.14B
2.15B
2.25B
Operating expense
1.67B
2.43B
2.40B
2.64B
Total operating expenses
4.47B
6.69B
6.48B
6.51B
Operating income
1.80B
1.96B
2.33B
858.06M
Other non operating income
22.65M
111.63M
-130.53M
228.47M
EBT including unusual items
1.32B
725.90M
990.25M
-157.26M
EBT excluding unusual items
1.44B
727.99M
988.87M
-157.26M
Income tax expense
194.58M
158.70M
348.00M
-49.27M
Effective tax rate
14.78%
21.86%
35.14%
31.33%
Other operating expenses
-
-
-
-
Net income
1.12B
567.20M
642.25M
-107.99M
Net profit margin
17.91%
6.56%
7.29%
-1.47%
Earnings per share
4.26
1.97
2.43
-0.41
Interest and investment income
31.75M
33.26M
28.46M
24.82M
Interest expense
-489.98M
-1.21B
-1.21B
-1.27B
Net interest expenses
-458.22M
-1.17B
-1.18B
-1.24B
Depreciation and amortization charges
-
-
-
-
EBITDA
2.21B
2.54B
2.92B
1.63B
Gain or loss from assets sale
4.03M
2.09M
-1.38M
-17.65M
Upcoming events
AI content may include mistakes. Learn more
Google apps